OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Income Before Tax

Profit after all operating and non-operating items but before income tax.

OrganiGram Holdings Inc.TSX: OGI.TO

Income Before Tax · Q2 FY2026 · quarter ended Mar 2026

Income before tax turns negative

Q2 FY2026 income before tax was -CA$921K, compared with CA$42.35M a year earlier. Trailing-twelve-month income before tax was -CA$38.87M.

Context

  • Income before tax amounted to 14.9% of revenue in FY2025, down 13.6 pp from a year earlier.
  • Income before tax grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly income before tax holds near -CA$921K or moves back toward the trailing-twelve-month quarterly average of -CA$9.72M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$921K-104.6% QoQ
Last fiscal yearSep 2025
-CA$38.53M+15.2% YoY
LTMMar 2026
-CA$38.87M-329.6% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-102.2%——
1 year+15.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

CAD · from the income statement

Latest · FY2025
(38.53M) CAD
Year-over-year change
+15.2%

Income Before Tax vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -329.6% is the lowest of 10, against a peer median of +37.4%.
  • Income before tax amounts to 14.2% of revenue for OGI.TO, versus a peer median of 18.8%.
OGI.TO Competitors
Income Before Tax for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DR.TOMedical Facilities CorporationLTM Mar 2026$56.04M USD+10.0%+32.0%18.4%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$32M CAD+134.4%—20.2%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$22.52M CAD+10.5%—7.1%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$20.21M USD+978.7%+15.0%39.7%
TSND.TOTerrAscend Corp.LTM Mar 2026$5.47M USD+111.0%—2.1%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$8.81M USD+37.4%—17.2%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026-$10.7M USD+23.0%—19.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$38.87M CAD-329.6%—14.2%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$42.19M USD-41.0%——
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$263.45M CAD+55.9%—84.7%
Peer median (excluding OGI.TO) —+37.4%+23.5%18.8%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M259.18M
Cost of Revenue107.56M114.24M114.13M112.32M249.67M
Gross Profit(28.4M)31.57M35.07M47.52M9.51M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.52M59.21M71.68M68.14M86.88M
Operating Expenses63.42M70.32M277.81M83.2M97.82M
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
EBITDA(95.59M)10.97M(207.62M)(23.59M)(20.55M)
EBITDA Margin-120.8%7.5%-139.2%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(88.31M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M3.31M1.15M
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M9.74M(9.77M)49.78M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(38.53M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)(5.28M)(13.77M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.19)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.19)
Weighted Avg Shares64.03M77.23M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M77.23M81.29M95.29M127.67M

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.